You are using an unsupported browser. Please upgrade your browser to a newer version to get the best experience on CypComp Database.
Record Information
Version1.0
Creation Date2019-07-14 16:36:10 UTC
Last Updated2019-10-01 21:41:12 UTC
CypComp IDCC01990
Compound Information
NameML-3403
Structure ImageVxpwqnbkeivyis oahllokosa n
InChIKeyVXPWQNBKEIVYIS-OAHLLOKOSA-N
PubChem ID10862355
CypCompound Information
SetCypBoM Training Set
Bonds of Metabolism (BoMs)
CYP1A2CYP2A6CYP2B6CYP2C8CYP2C9CYP2C19CYP2D6CYP2E1CYP3A4
  • <1,S;Oxidation;R1>
  • Not Available
  • Not Available
  • <1,S;Oxidation;R1>
  • <1,S;Oxidation;R1>
  • <1,S;Oxidation;R1>
  • <1,S;Oxidation;R1>
  • Not Available
  • <7,3;Cleavage;R1>
  • <7,H;Oxidation;R1>
  • <1,S;Oxidation;R2>
  • <6,N;Oxidation;R3>
References
  1. Kammerer B, Scheible H, Albrecht W, Gleiter CH, Laufer S: Pharmacokinetics of ML3403 ({4-[5-(4-fluorophenyl)-2-methylsulfanyl-3H-imidazol-4-yl]-pyridin-2-yl}-(1-pheny lethyl)-amine), a 4-Pyridinylimidazole-type p38 mitogen-activated protein kinase inhibitor. Drug Metab Dispos. 2007 Jun;35(6):875-83. doi: 10.1124/dmd.106.013409. Epub 2007 Mar 7. [PubMed:17344341 ]
Download FileCC01990.sdf